REAP Financial Group’s Heart Test Laboratories HSCS Stock Holding History
Bought
Maintained
Sold
Other funds holding HSCS
DS
TA
ASW
TRCT
FDCDDQ
REAP Financial Group's HSCS Position: Q4 2025 in Review
REAP Financial Group sold out of Heart Test Laboratories (HSCS) in Q4 2025, closing a stake of 380 shares — an estimated $1.32K sold.
REAP Financial Group first reported a position in HSCS in Q3 2025 and held it in 1 quarter. The position peaked at $1.32K in Q3 2025. 10 funds tracked by Wall St. Rank hold HSCS as of Q4 2025.
- REAP Financial Group reported no remaining Heart Test Laboratories position as of Q4 2025 after selling out during the quarter.
- REAP Financial Group sold 380 Heart Test Laboratories shares in Q4 2025, an estimated $1.32K.
- REAP Financial Group first reported a position in Heart Test Laboratories in Q3 2025 and held it in 1 quarter.
- REAP Financial Group's Heart Test Laboratories position peaked at $1.32K in Q3 2025.
- 10 funds tracked by Wall St. Rank held Heart Test Laboratories as of Q4 2025.
Based on REAP Financial Group's 13F filing for Q4 2025, filed 10 Feb 2026.